This researcher was proven to have committed severe plagiarism (>40%) in the article titled "Novel Therapeutic Approaches for Cardiovascular Diseases" published in the Journal of Medical Research. Similarity analysis shows copy-pasting from 3 different articles without proper attribution.

Furthermore, indications of data fabrication were found in the study regarding statin side effects. Patient data in the control and treatment groups showed unnatural patterns and significant statistical inconsistencies.

The researcher also engaged in duplicate publication (self-plagiarism) by publishing the same research results in two different journals with minor changes to the title and abstract.

1. The article "Safety Profile of Statin Therapy in Elderly Patients" has been retracted by the European Journal of Cardiology.

2. The researcher is subjected to a 3-year submission ban to journals within the Elsevier group.

3. The University of São Paulo is conducting an internal investigation and will likely impose disciplinary sanctions.

4. All of the researcher's publications in the last 5 years are under verification by the ethics committee.